Predictive Oncology Net Profit Margin 2010-2025 | POAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Predictive Oncology net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Predictive Oncology net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$47.5B
Tempus AI (TEM)	$14B
Doximity (DOCS)	$12.7B
Hims & Hers Health (HIMS)	$10.1B
IRhythm Technologies (IRTC)	$5.4B
Hinge Health (HNGE)	$4.5B
Inspire Medical Systems (INSP)	$2.8B
Privia Health (PRVA)	$2.7B
Heartflow (HTFL)	$2.4B
Enovis (ENOV)	$1.8B
10x Genomics (TXG)	$1.8B
Phreesia (PHR)	$1.8B
Omnicell (OMCL)	$1.5B
Schrodinger (SDGR)	$1.5B
Azenta (AZTA)	$1.4B
Clover Health Investments (CLOV)	$1.4B
Claritev (CTEV)	$1.2B
Evolent Health (EVH)	$1.1B
Fulgent Genetics (FLGT)	$666M
Zepp Health (ZEPP)	$580M
Veradigm (MDRX)	$525M
Standard BioTools (LAB)	$485M
Talkspace (TALK)	$469M
Butterfly Network (BFLY)	$383M
Carlsmed (CARL)	$346M
TruBridge (TBRG)	$307M
Outset Medical (OM)	$252M
SOPHiA GENETICS SA (SOPH)	$244M
Health Catalyst (HCAT)	$231M
Nyxoah SA (NYXH)	$219M